Clinical value of preferred endoscopic ultrasound guided antegrade surgery in the precise treatment of extrahepatic bile duct malignant obstruction

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047026

Enrollment

Unknown

Registered

2021-06-07

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive jaundice

Interventions

Experimental group1:EUS-Antegrade

Experimental group2:ERCP-guided biliary drainage

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The presence of malignant extrahepatic bile duct obstruction and intrahepatic bile duct dilatation was confirmed by imaging or pathological examination; 2. Radical surgical resection could not be performed due to advanced malignant tumor or concomitant disease; 3. Informed consent of the patient.

Exclusion criteria

Exclusion criteria: 1. Patients with severe coagulation dysfunction or platelet abnormalities; 2. Patients with liver cirrhosis, severe esophagus stricture, and severe esophageal gastric varices; 3. Patients with severe diabetes, high refractory; 4. Patients who cannot tolerate endoscopic surgery.

Design outcomes

Primary

Measure	Time frame
Total bilirubin;	—

Countries

China

Contacts

Public ContactZhu Sumin

The Second Affiliated Hospital of Xuzhou Medical University

781119938@qq.com+86 17751991916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026